T6039 |
TAK-285
|
TAK 285 , TAK285 |
EGFR
,
MEK
,
HER
,
Aurora Kinase
|
|
TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than... |
T5398 |
BMS 599626 2HCl (873837-23-1(HCl))
|
AC480 dihydrochloride |
HER
|
|
BMS-599626 (AC480) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100... |
T8758 |
Poziotinib hydrochloride
|
HM 781-36B hydrochloride , NOV120101 hydrochloride |
EGFR
|
|
Poziotinib hydrochloride irreversibly inhibits EGFR (HER1 or ErbB1), including EGFR mutants, HER2, and HER4, thereby inh... |
T9912 |
Trastuzumab
|
|
EGFR
|
|
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzu... |
T22974 |
Methyl 2,5-dihydroxycinnamate
|
|
EGFR
|
|
EGF receptor-associated tyrosine kinases inhibitor |
T3466 |
FIIN-3
|
|
EGFR
,
FGFR
|
|
FIIN-3 is an irreversible inhibitor of FGFR. |
T3545 |
RG13022
|
RG 13022 , Tyrphostin RG13022 |
EGFR
|
|
RG13022 is a tyrosine kinase inhibitor; inhibits the autophosphorylation reaction of the EGF receptor (IC50: 4 μM). |
T39275 |
Befotertinib
|
D-0316 |
EGFR
|
|
Befotertinib is an inhibitor of EGFR tyrosine kinase and can be used for studies about EGFR T790M-positive non-small cel... |
T21954 |
EGFR/ErbB-2/ErbB-4 inhibitor-2
|
EGFR/ErbB2 Inhibitor |
EGFR
|
|
EGFR/ErbB2 Inhibitor is a cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, respectively) |
T60076 |
Oritinib
|
SH-1028 |
EGFR
|
|
Oritinib is an inhibitor of EGFR with IC50s of 18, 0.7, 4, 0.1, 1.4 and 0.89 nM for EGFR (wt), EGFR (L858R), EGFR (L861Q... |
TQ0166 |
Tesevatinib
|
XL-647 , EXEL-7647 , KD-019 |
VEGFR
,
EGFR
,
FLT
,
Ephrin Receptor
|
|
Tesevatinib is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, and 1.4 nM for EGF... |
T21641 |
Vandetanib hydrochloride
|
|
|
|
Vandetanib hydrochloride (D6474 hydrochloride) is a potent, orally active inhibitor of VEGFR2/KDR tyrosine kinase activi... |
T22610 |
BMS 599626 dihydrochloride (714971-09-2 free base)
|
BMS 599626 dihydrochloride |
Others
|
|
BMS 599626 dihydrochloride is a potent and selective EGFR and ErbB2 inhibitor. BMS-599626 inhibited HER4 (IC50: 190 nM).... |
T22272 |
Lifirafenib
|
BGB-283 , Beigene-283 |
EGFR
,
Raf
|
|
Lifirafenib is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM fo... |
T9922 |
Matuzumab
|
|
EGFR
|
|
Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associ... |
T9927 |
Panitumumab
|
|
EGFR
|
|
Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR). |
T2630 |
Poziotinib
|
HM781-36B , NOV120101 |
EGFR
,
Apoptosis
,
HER
|
|
Poziotinib(NOV120101; HM781-36B) is an irreversible HER1/2/4 inhibitor (IC50s: 3/5/23 nM). |
T5390 |
BMS-599626 Hydrochloride
|
|
HER
|
|
BMS-599626 Hydrochloride (AC480 Hydrochloride) is a selective and orally bioavailable HER1 and HER2 inhibitor, with IC 5... |
T6719 |
Varlitinib
|
ARRY-334543 , ASLAN001 |
HER
|
|
Varlitinib is a potent, reversible, small molecule pan-EGFR inhibitor with IC50s of 7, 2, 4 nM for HER1, HER2 and HER4, ... |
T64176 |
Vandetanib trifluoroacetate
|
|
|
|
Vandetanib trifluoroacetate (D6474 trifluoroacetate) is a potent, orally active inhibitor of VEGFR2/KDR tyrosine kinase ... |